Life · 6 authors, 6 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This narrative review examines the application of cardiovascular risk prediction scores in patients with non-alcoholic fatty liver disease (NAFLD) and concludes that current scores may underestimate risk and that new, inclusive scores incorporating liver fibrosis severity are needed.
This narrative review discusses the epidemiological overlap between cardiovascular disease (CVD) and non-alcoholic fatty liver disease (NAFLD). It notes that people with NAFLD have a twofold increased risk of cardiovascular events, which is doubled in those with liver fibrosis. The authors state that traditional CVD risk scores tend to underestimate risk in NAFLD patients and that no score specific to this population has been validated. The review argues that assessing NAFLD and liver fibrosis severity could be important for future risk scores. The central conclusion is that prospective long-term studies are needed to determine if NAFLD diagnosis improves CVD risk stratification, and that new risk scores are required for complex patients.
